Compile Data Set for Download or QSAR
maximum 50k data
Found 549 Enz. Inhib. hit(s) with all data for entry = 10309
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526861(US11186577, Cmpd. No. 203A | US11186577, Cmpd. No....)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526863(US11186577, Cmpd. No. 204A | US11186577, Cmpd. No....)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526865(US11186577, Cmpd. No. 205A | US11186577, Cmpd. No....)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526867(US11186577, Cmpd. No. 206A | US11186577, Cmpd. No....)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526869(US11186577, Cmpd. No. 217)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526870(US11186577, Cmpd. No. 218)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526871(US11186577, Cmpd. No. 219)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526872(US11186577, Cmpd. No. 220)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526873(US11186577, Cmpd. No. 221)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526874(US11186577, Cmpd. No. 222)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526875(US11186577, Cmpd. No. 223)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526875(US11186577, Cmpd. No. 223)
Affinity DataIC50: <100nMAssay Description:The purpose of the assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin receptor 2. The assay was performed in co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526876(US11186577, Cmpd. No. 224)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526877(US11186577, Cmpd. No. 225)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526878(US11186577, Cmpd. No. 226)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526879(US11186577, Cmpd. No. 227)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526880(US11186577, Cmpd. No. 228)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526881(US11186577, Cmpd. No. 229)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V2 receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526881(US11186577, Cmpd. No. 229)
Affinity DataIC50: <100nMAssay Description:The purpose of the assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin receptor 2. The assay was performed in co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526882(US11186577, Cmpd. No. 230)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526884(US11186577, Cmpd. No. 232)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526885(US11186577, Cmpd. No. 233)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526887(US11186577, Cmpd. No. 235)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526888(US11186577, Cmpd. No. 236)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526889(US11186577, Cmpd. No. 237)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526890(US11186577, Cmpd. No. 238)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526892(US11186577, Cmpd. No. 240)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526893(US11186577, Cmpd. No. 241)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526894(US11186577, Cmpd. No. 242)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526896(US11186577, Cmpd. No. 244)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526897(US11186577, Cmpd. No. 245)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526898(US11186577, Cmpd. No. 246)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526899(US11186577, Cmpd. No. 247)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526900(US11186577, Cmpd. No. 248)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526901(US11186577, Cmpd. No. 249)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526902(US11186577, Cmpd. No. 250)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526904(US11186577, Cmpd. No. 252)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526907(US11186577, Cmpd. No. 255)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526908(US11186577, Cmpd. No. 256)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526911(US11186577, Cmpd. No. 259)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526912(US11186577, Cmpd. No. 260)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526913(US11186577, Cmpd. No. 261)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526914(US11186577, Cmpd. No. 262)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526915(US11186577, Cmpd. No. 263)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526916(US11186577, Cmpd. No. 264)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526923(US11186577, Cmpd. No. 271)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526924(US11186577, Cmpd. No. 272)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526925(US11186577, Cmpd. No. 273)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526926(US11186577, Cmpd. No. 274)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetVasopressin V1a receptor(Homo sapiens (Human))
Blackthorn Therapeutics

US Patent
LigandPNGBDBM526927(US11186577, Cmpd. No. 275)
Affinity DataIC50: <100nMAssay Description:The purpose of this assay was to determine the inhibitory effect of synthesized compounds on the Vasopressin V1a receptor. The assay as performed in ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 549 total ) | Next | Last >>
Jump to: